HK1122819A1 - Novel peptide compounds from wilms' tumor - Google Patents
Novel peptide compounds from wilms' tumorInfo
- Publication number
- HK1122819A1 HK1122819A1 HK08113820.1A HK08113820A HK1122819A1 HK 1122819 A1 HK1122819 A1 HK 1122819A1 HK 08113820 A HK08113820 A HK 08113820A HK 1122819 A1 HK1122819 A1 HK 1122819A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- wilms
- tumor
- peptide compounds
- novel peptide
- novel
- Prior art date
Links
- 208000008383 Wilms tumor Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001152—Transcription factors, e.g. SOX or c-MYC
- A61K39/001153—Wilms tumor 1 [WT1]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005346577 | 2005-11-30 | ||
PCT/JP2006/323827 WO2007063903A1 (ja) | 2005-11-30 | 2006-11-29 | 新規ペプチド化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1122819A1 true HK1122819A1 (en) | 2009-05-29 |
Family
ID=38092236
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08113820.1A HK1122819A1 (en) | 2005-11-30 | 2008-12-19 | Novel peptide compounds from wilms' tumor |
HK16109195.6A HK1221230A1 (zh) | 2005-11-30 | 2016-08-02 | 新型肽化合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16109195.6A HK1221230A1 (zh) | 2005-11-30 | 2016-08-02 | 新型肽化合物 |
Country Status (18)
Country | Link |
---|---|
US (4) | US7939627B2 (xx) |
EP (1) | EP1961761B1 (xx) |
JP (4) | JP4394724B2 (xx) |
KR (1) | KR101385805B1 (xx) |
CN (2) | CN101336249A (xx) |
AU (1) | AU2006319892B2 (xx) |
BR (1) | BRPI0619255B8 (xx) |
CA (1) | CA2631292C (xx) |
DE (1) | DE602006017880D1 (xx) |
DK (1) | DK1961761T3 (xx) |
ES (1) | ES2352855T3 (xx) |
HK (2) | HK1122819A1 (xx) |
PL (1) | PL1961761T3 (xx) |
PT (1) | PT1961761E (xx) |
RU (1) | RU2424247C2 (xx) |
SI (1) | SI1961761T1 (xx) |
TW (1) | TWI372152B (xx) |
WO (1) | WO2007063903A1 (xx) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101213015B1 (ko) | 2003-11-05 | 2012-12-26 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Wt1 로부터 유도된 hla-dr 결합성 항원 펩티드 |
AU2006304573B2 (en) | 2005-10-17 | 2012-05-24 | Sloan Kettering Institute For Cancer Research | WT1 HLA class II-binding peptides and compositions and methods comprising same |
CN101336249A (zh) * | 2005-11-30 | 2008-12-31 | 株式会社癌免疫研究所 | 新型肽化合物 |
EP3117836A1 (en) | 2006-04-10 | 2017-01-18 | Sloan Kettering Institute For Cancer Research | Immunogenic wt-1 peptides and uses thereof |
CN104774910B (zh) | 2007-02-27 | 2018-04-10 | 株式会社癌免疫研究所 | 活化辅助t细胞的方法以及用于该方法的组合物 |
JP2011016751A (ja) * | 2009-07-08 | 2011-01-27 | Sumitomo Chemical Co Ltd | 光学活性3−アミノピペリジン−1−カルボキシレート化合物の製造方法およびその製造方法に用いられる中間体 |
GB2499480A (en) | 2010-03-31 | 2013-08-21 | Stabilitech Ltd | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
GB2499479A (en) | 2010-03-31 | 2013-08-21 | Stabilitech Ltd | Stabilisation of viral particles |
HUE033656T2 (en) | 2010-03-31 | 2017-12-28 | Stabilitech Ltd | Binders for stabilizing virus particles |
ES2849187T3 (es) | 2010-10-05 | 2021-08-16 | Int Inst Cancer Immunology Inc | Método para activar células T auxiliares |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
US9539299B2 (en) * | 2011-10-27 | 2017-01-10 | International Institute Of Cancer Immunology, Inc. | Combination therapy with WT1 peptide vaccine and temozolomide |
JP6282598B2 (ja) * | 2012-01-13 | 2018-02-21 | メモリアル スローン ケタリング キャンサー センター | 免疫原性wt1ペプチド及びその使用方法 |
ES2655031T3 (es) | 2012-07-02 | 2018-02-16 | Sumitomo Dainippon Pharma Co., Ltd. | Preparación transdérmica de péptido antigénico del cáncer |
KR101810840B1 (ko) * | 2012-12-13 | 2017-12-20 | 루프레히트-칼스-유니페어지테트 하이델베르크 | 암의 예방 및 치료용 msi-특이적 프레임쉬프트 펩티드(fsp) |
JP6530192B2 (ja) | 2012-12-17 | 2019-06-12 | 大塚製薬株式会社 | ヘルパーt細胞の活性化方法 |
US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
CN116789792A (zh) * | 2013-01-15 | 2023-09-22 | 纪念斯隆凯特林癌症中心 | 免疫原性wt-1肽和其使用方法 |
EP2762160A1 (en) | 2013-02-05 | 2014-08-06 | Nitto Denko Corporation | Wt1 peptide cancer vaccine composition for mucosal administration |
RU2697443C2 (ru) | 2013-02-05 | 2019-08-14 | Нитто Денко Корпорейшн | Препарат противораковой вакцины, содержащий пептид wt1, в форме ленты трансдермального введения |
US10071051B2 (en) | 2013-02-05 | 2018-09-11 | Nitto Denko Corporation | WT1 peptide cancer vaccine composition for transdermal administration |
RU2687144C2 (ru) | 2013-02-05 | 2019-05-07 | Нитто Денко Корпорейшн | Композиция противораковой вакцины, содержащей пептид wt1, для трансдермального введения |
AU2014227019B2 (en) * | 2013-03-08 | 2016-10-27 | Taiho Pharmaceutical Co., Ltd. | Novel peptide having 5 linked CTL epitopes |
JP6294868B2 (ja) | 2013-03-12 | 2018-03-14 | 大日本住友製薬株式会社 | 液体水性組成物 |
DK2982681T3 (en) | 2013-03-29 | 2018-12-10 | Sumitomo Dainippon Pharma Co Ltd | WT1 ANTIGENPEPTIDKONJUGATVACCINE |
JP6671956B2 (ja) * | 2013-03-29 | 2020-03-25 | 大日本住友製薬株式会社 | Erap1によるトリミング機能をきっかけとしたコンジュゲートワクチン |
PT3061771T (pt) | 2013-10-21 | 2020-05-06 | Taiho Pharmaceutical Co Ltd | Novo péptido unido a quatro epitopos ctl |
GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
US10471136B2 (en) | 2014-09-27 | 2019-11-12 | Sumitomo Dainippon Pharma Co., Ltd. | Pharmaceutical composition for injection |
JP6671141B2 (ja) * | 2014-10-21 | 2020-03-25 | 大日本住友製薬株式会社 | 懸濁液剤 |
JP6699013B2 (ja) * | 2014-12-25 | 2020-05-27 | 国立大学法人三重大学 | Wt1由来ペプチド認識抗体 |
US20200016255A1 (en) | 2016-11-30 | 2020-01-16 | Sumitomo Dainippon Pharma Co., Ltd. | Wt1 helper peptides and combinations of wt1 helper peptide and conjugate of cancer antigen peptides |
WO2018181648A1 (ja) | 2017-03-30 | 2018-10-04 | 大日本住友製薬株式会社 | Wt1癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体 |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
EP3858377A4 (en) | 2018-09-28 | 2022-11-30 | Sumitomo Pharma Co., Ltd. | INJECTABLE COMPOSITION |
CA3115240A1 (en) | 2018-10-05 | 2020-04-09 | International Institute Of Cancer Immunology, Inc. | Composition for preventing or treating benign tumor |
CA3127312A1 (en) * | 2019-02-13 | 2020-08-20 | Sumitomo Dainippon Pharma Co., Ltd. | Hemiasterlin derivative having cysteine residue |
MX2021012200A (es) | 2019-04-05 | 2022-01-06 | Sumitomo Pharma Co Ltd | Adyuvante soluble en agua y composición que contiene el mismo. |
WO2020204172A1 (ja) | 2019-04-05 | 2020-10-08 | 大日本住友製薬株式会社 | 水溶性アジュバント |
AU2021272616A1 (en) | 2020-05-12 | 2022-12-15 | International Institute Of Cancer Immunology, Inc. | Pharmaceutical composition for treating cancer |
AU2022327884A1 (en) | 2021-08-12 | 2024-02-22 | International Institute Of Cancer Immunology, Inc. | Pharmaceutical composition and method for treatment or prevention of cancer |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858358A (en) * | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
US6297041B1 (en) * | 1992-03-11 | 2001-10-02 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
US6309642B1 (en) * | 1997-04-28 | 2001-10-30 | The Research And Development Institute, Inc. | Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
US5858682A (en) * | 1996-08-02 | 1999-01-12 | Pharmingen | E2A/pbx1 fusion protein specific monoclonal antibodies |
CN1560078B (zh) * | 1998-07-31 | 2011-06-22 | 株式会社国际癌症免疫研究所 | 基于癌抑制基因wt1的产物的癌抗原 |
CA2349442C (en) | 1998-09-30 | 2012-12-04 | Corixa Corporation | Compositions and methods for wt1 specific immunotherapy |
GB9823897D0 (en) | 1998-11-02 | 1998-12-30 | Imp College Innovations Ltd | Immunotherapeutic methods and molecules |
US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
CA2440303C (en) * | 2001-03-22 | 2013-03-19 | Haruo Sugiyama | Wt1 modified peptide |
AU2002252638A1 (en) * | 2001-04-17 | 2002-10-28 | Children's Hospital Oakland Research Institute | Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
US8735357B2 (en) * | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
JPWO2003028758A1 (ja) * | 2001-09-28 | 2005-01-13 | 治夫 杉山 | 抗原特異的t細胞の誘導方法 |
ATE466084T1 (de) * | 2002-06-12 | 2010-05-15 | Int Inst Cancer Immunology Inc | Hla-a24-restringiertes krebsantigenpeptid |
ES2538486T3 (es) * | 2002-09-12 | 2015-06-22 | International Institute Of Cancer Immunology, Inc. | Preparación de péptidos antigénicos contra el cáncer |
ATE442378T1 (de) | 2002-09-20 | 2009-09-15 | Int Inst Cancer Immunology Inc | Substituierte wt1-peptide |
CA2513366A1 (en) * | 2003-01-13 | 2004-07-29 | Richard Wodzianek | Host extensible wireless application interface |
US20060217297A1 (en) * | 2003-01-15 | 2006-09-28 | Haruo Sugiyama | Dimerized peptide |
ES2478446T3 (es) * | 2003-06-27 | 2014-07-22 | International Institute Of Cancer Immunology, Inc. | Método de selección de pacientes candidatos para la vacuna contra WT1 |
KR101213015B1 (ko) | 2003-11-05 | 2012-12-26 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Wt1 로부터 유도된 hla-dr 결합성 항원 펩티드 |
EP1703887A4 (en) * | 2003-12-31 | 2009-10-21 | Univ Rochester | IMMUNOGENIC POLYPEPTIDES AND CONJUGATES THAT CAN INDUCE ANTIBODIES AGAINST PATHOGENIC AGENTS AND USES THEREOF |
SI1731605T1 (sl) | 2004-03-31 | 2010-07-30 | Internat Inst Of Cancer Immunolog Inc | Peptidi antigena karcinoma izvedeni iz WT1 |
US7241580B2 (en) * | 2004-06-08 | 2007-07-10 | Wisconsin Alumni Research Foundation | Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies |
CN101336249A (zh) * | 2005-11-30 | 2008-12-31 | 株式会社癌免疫研究所 | 新型肽化合物 |
-
2006
- 2006-11-29 CN CNA2006800519144A patent/CN101336249A/zh active Pending
- 2006-11-29 PL PL06833631T patent/PL1961761T3/pl unknown
- 2006-11-29 SI SI200630824T patent/SI1961761T1/sl unknown
- 2006-11-29 KR KR1020087015751A patent/KR101385805B1/ko active IP Right Grant
- 2006-11-29 DK DK06833631.2T patent/DK1961761T3/da active
- 2006-11-29 ES ES06833631T patent/ES2352855T3/es active Active
- 2006-11-29 CA CA2631292A patent/CA2631292C/en active Active
- 2006-11-29 EP EP06833631A patent/EP1961761B1/en active Active
- 2006-11-29 AU AU2006319892A patent/AU2006319892B2/en active Active
- 2006-11-29 DE DE602006017880T patent/DE602006017880D1/de active Active
- 2006-11-29 RU RU2008126305/04A patent/RU2424247C2/ru active
- 2006-11-29 CN CN201510909871.XA patent/CN105315347A/zh active Pending
- 2006-11-29 WO PCT/JP2006/323827 patent/WO2007063903A1/ja active Application Filing
- 2006-11-29 PT PT06833631T patent/PT1961761E/pt unknown
- 2006-11-29 US US12/095,418 patent/US7939627B2/en active Active
- 2006-11-29 JP JP2007547975A patent/JP4394724B2/ja active Active
- 2006-11-29 BR BRPI0619255A patent/BRPI0619255B8/pt active IP Right Grant
- 2006-11-30 TW TW095144507A patent/TWI372152B/zh active
-
2008
- 2008-12-19 HK HK08113820.1A patent/HK1122819A1/xx unknown
-
2009
- 2009-08-31 JP JP2009200003A patent/JP5049323B2/ja active Active
-
2011
- 2011-03-22 US US13/053,996 patent/US8575308B2/en active Active
-
2012
- 2012-03-29 JP JP2012077513A patent/JP5597668B2/ja active Active
-
2013
- 2013-09-10 US US14/022,413 patent/US9273148B2/en active Active
-
2014
- 2014-01-31 JP JP2014017168A patent/JP5800928B2/ja active Active
-
2016
- 2016-02-26 US US15/054,805 patent/US9765114B2/en active Active
- 2016-08-02 HK HK16109195.6A patent/HK1221230A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1122819A1 (en) | Novel peptide compounds from wilms' tumor | |
IL246171A0 (en) | Peptide-based compounds | |
EP1824976A4 (en) | ANTIMICROBIAL PEPTIDES | |
HK1090350A1 (en) | Novel aminobenzophenone compounds | |
EP1966235A4 (en) | ANTIMICROBIAL PEPTIDES OF CATHELICIDINE | |
ZA200704809B (en) | Triazole substituted aminobenzophenone compounds | |
HK1114777A1 (en) | Novel antimicrobial peptides | |
EP1596860A4 (en) | NEW CONNECTIONS | |
EP1648885A4 (en) | NEW CONNECTIONS | |
EP1939286A4 (en) | NEW PEPTIDE | |
GB0302431D0 (en) | Novel compounds | |
GB0302546D0 (en) | Novel compounds | |
EP1635834A4 (en) | NEW COMPOUNDS | |
HK1117152A1 (en) | Triazole substituted aminobenzophenone compounds | |
SI1828148T1 (sl) | S triazolom nadomeĺ äśeni aminobenzofenonski sestavki | |
GB0418183D0 (en) | Compound libraries 15 | |
GB0413812D0 (en) | Compound libraries 9 | |
GB0418182D0 (en) | Compound libraries 14 | |
GB0414058D0 (en) | Compound libraries 12 | |
SI1658263T1 (sl) | Nove spojine aminobenzofenona | |
GB0301955D0 (en) | Novel compounds | |
GB0303464D0 (en) | Novel compounds | |
GB0301592D0 (en) | Novel compounds | |
GB0301608D0 (en) | Novel compounds | |
GB0301593D0 (en) | Novel compounds |